Wu IB, Schwartz RA. Reiter’s syndrome: the classic triad and more. J Am Academy of Dermatol. 2008;59(1):113–21. https://doi.org/10.1016/j.jaad.2008.02.047.

Article  Google Scholar 

Fendler C, Laitko S, Sörensen H, Gripenberg-Lerche C, Groh A, Uksila J, Granfors K, Braun J, Sieper J. Frequency of triggering bacteria in patients with reactive arthritis and undifferentiated oligoarthritis and the relative importance of the tests used for diagnosis. Ann Rheum Dis. 2001;60(4):337–43. https://doi.org/10.1136/ard.60.4.337.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Selmi C, Gershwin ME. Diagnosis and classification of reactive arthritis. Autoimmun Rev. 2014;13(4–5):546–9. https://doi.org/10.1016/j.autrev.2014.01.005.

Article  CAS  PubMed  Google Scholar 

Rudwaleit MV, Van Der Heijde D, Landewé R, Listing J, Akkoc N, Brandt J, Braun J, Chou CT, Collantes-Estevez E, Dougados M, Huang F. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis. 2009;68(6):777–83. https://doi.org/10.1136/ard.2009.108233.

Article  CAS  PubMed  Google Scholar 

Rudwaleit MV, van der Heijde D, Landewé R, Akkoc N, Brandt J, Chou CT, Dougados M, Huang F, Gu J, Kirazli Y, Van den Bosch F. The Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general. Ann rheum Dis. 2011;70(1):25–31. https://doi.org/10.1136/ard.2010.133645.

Article  CAS  PubMed  Google Scholar 

Sieper J. Pathogenesis of reactive arthritis. Curr Rheumatol Rep. 2001;3(5):412–8. https://doi.org/10.1007/s11926-996-0012-8.

Article  CAS  PubMed  Google Scholar 

Carter JD. Reactive arthritis: defined etiologies, emerging pathophysiology, and unresolved treatment. Infect Dis Clin. 2006;20(4):827–47. https://doi.org/10.1016/j.idc.2006.09.004.

Article  Google Scholar 

Ngaruiya CM, Martin IB. A case of reactive arthritis: a great masquerader. Am J Emerg Med. 2012;31(1):266-e5. https://doi.org/10.1016/j.ajem.2012.04.019.

Article  Google Scholar 

Yin Z, Braun J, Neure L, Wu P, Liu L, Eggens U, Sieper J. Crucial role of interleukin-10/interleukin-12 balance in the regulation of the type 2 T helper cytokine response in reactive arthritis. Arthr Rheum. 1997;40(10):1788–97. https://doi.org/10.1002/art.1780401010.

Article  CAS  Google Scholar 

Wendling D, Cedoz JP, Racadot E. Serum and synovial fluid levels of p40 IL12/23 in spondyloarthropathy patients. Clin Rheumatol. 2009;28:187–90. https://doi.org/10.1007/s10067-008-1011-0.

Article  PubMed  Google Scholar 

Meador R, Hsia E, Kitumnuaypong T, Schumacher HR. TNF involvement and anti-TNF therapy of reactive and unclassified arthritis. Clin Exp Rheumatol. 2002;20(6; SUPP/28):S-130.

CAS  Google Scholar 

Singh R, Aggarwal A, Misra R. Th1/Th17 cytokine profiles in patients with reactive arthritis/undifferentiated spondyloarthropathy. J Rheumatol. 2007;34(11):2285–90.

CAS  PubMed  Google Scholar 

Holt I, Cooper RG, Hopkins SJ. Relationships between local inflammation, interleukin-6 concentration and the acute phase protein response in arthritis patients. Eur J Clin Investig. 1991;21(5):479–84. https://doi.org/10.1111/j.1365-2362.1991.tb01398.x.

Article  CAS  Google Scholar 

Chaurasia S, Shasany AK, Aggarwal A, Misra R. Recombinant Salmonella typhimurium outer membrane protein A is recognized by synovial fluid CD8 cells and stimulates synovial fluid mononuclear cells to produce interleukin (IL)-17/IL-23 in patients with reactive arthritis and undifferentiated spondyloarthropathy. Clin Exp Immunol. 2016;185(2):210–8. https://doi.org/10.1111/cei.12799.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Noto Llana M, Sarnacki SH, Aya Castañeda MD, Bernal MI, Giacomodonato MN, Cerquetti MC. Consumption of Lactobacillus casei fermented milk prevents Salmonella reactive arthritis by modulating IL-23/IL-17 expression. PLoS One. 2013;8(12):e82588. https://doi.org/10.1371/journal.pone.0082588.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Padhan P, Maikap D. Secukinumab therapy in reactive arthritis: Report of two cases. Modern Rheumatol Case Rep. 2022;6(1):22–4. https://doi.org/10.1093/mrcr/rxab014.

Article  Google Scholar 

Gupta V, Mohta P, Sharma VK, Khanna N. A retrospective case series of 12 patients with chronic reactive arthritis with emphasis on treatment outcome with biologics. Indian J Dermatol Venereol Leprol. 2021;87(2):227–34. https://doi.org/10.4103/ijdvl.IJDVL_519_18.

Article  PubMed  Google Scholar 

Ahmed S, Padhan P. AB0632 Effectiveness of etanercept biosimilars in reactive arthritis: retrospective case control. Ann Rheum Dis. 2020;79:1611–2. https://doi.org/10.1136/annrheumdis-2020-eular.295.

Article  Google Scholar 

Van Mens LJ, van de Sande MG, Menegatti S, Chen S, Blijdorp IC, de Jong HM, Fluri IA, Latuhihin TE, van Kuijk AW, Rogge L, Yeremenko NG. Brief report: interleukin-17 blockade with secukinumab in peripheral spondyloarthritis impacts synovial immunopathology without compromising systemic immune responses. Arthr Rheumatol. 2018;70(12):1994–2002. https://doi.org/10.1002/art.40581.

Article  CAS  Google Scholar 

Brinster A, Guillot X, Prati C, Wendling D. Anti-TNF treatment of reactive arthritis. A monocentric experience. Joint Bone Spine. 2017;84(2):237–8. https://doi.org/10.1016/j.jbspin.2016.02.022.

Article  CAS  PubMed  Google Scholar 

Ahogo KC, Bataille M, Lasek A, Wantz M, Lebas D, Modiano P. A case of reactive arthritis (oculo-urethro-synovial syndrome) treated with infliximab. Ann Dermatol Venereo. 2017;144:804–5. https://doi.org/10.1016/j.annder.2017.08.004.

Article  Google Scholar 

Edrees A. Successful use of etanercept for the treatment of Reiter’s syndrome: a case report and review of the literature. Rheumatol Int. 2012;32:1–3. https://doi.org/10.1007/s00296-011-2000-1.

Article  PubMed  Google Scholar 

Gaylis NB. Long-term follow-up of an HIV-infected patient with reactive arthritis treated with infliximab. JCR: J Clin Rheumatol. 2012;18(3):153–4. https://doi.org/10.1097/RHU.0b013e31824e9151.

Article  PubMed  Google Scholar 

Meyer A, Chatelus E, Wendling D, Berthelot JM, Dernis E, Houvenagel E, Morel J, Richer O, Schaeverbeke T, Gottenberg JE, Sibilia J. Safety and efficacy of anti–tumor necrosis factor α therapy in ten patients with recent-onset refractory reactive arthritis. Arthr Rheum. 2011;63(5):1274–80. https://doi.org/10.1002/art.30272.

Article  CAS  Google Scholar 

Schafranski MD. Infliximab for reactive arthritis secondary to Chlamydia trachomatis infection. Rheumatology international. 2010;30(5):679–80. https://doi.org/10.1007/s00296-009-0965-9.

Article  CAS  PubMed  Google Scholar 

Wechalekar MD, Rischmueller M, Whittle S, Burnet S. Hill CL 2010 Prolonged remission of chronic reactive arthritis treated with three infusions of infliximab. JCR: J Clin Rheumatol. 2010;16(2):79–80. https://doi.org/10.1097/RHU.0b013e3181d06f70.

Article  PubMed  Google Scholar 

Tanaka T, Kuwahara Y, Shima Y, Hirano T, Kawai M, Ogawa M, Arimitsu J, Hagihara K, Narazaki M, Ogata A, Kawase I. Successful treatment of reactive arthritis with a humanized anti–interleukin-6 receptor antibody, tocilizumab. Arthr Care Res. 2009;61(12):1762–4. https://doi.org/10.1002/art.24899.

Article  Google Scholar 

Gill H, Majithia V. Successful use of infliximab in the treatment of Reiter’s syndrome: a case report and discussion. Clin Rheumatol. 2008;27:121–3. https://doi.org/10.1007/s10067-007-0692-0.

Article  PubMed  Google Scholar 

Sánchez-Cano D, Callejas-Rubio JL, Ortego-Centeno N. Use of adalimumab in poststreptococcal reactive arthritis. JCR: J Clin Rheumatol. 2007;13(3):176. https://doi.org/10.1097/RHU.0b013e3180690c1f.

Article  PubMed  Google Scholar 

Flagg SD, Meador R, Hsia E, Kitumnuaypong T, Schumacher HR Jr. Decreased pain and synovial inflammation after etanercept therapy in patients with reactive and undifferentiated arthritis: an open-label trial. Arthr Care Res: Off J Am Coll Rheumatol. 2005;53(4):613–7. https://doi.org/10.1002/art.21323.

Article  CAS  Google Scholar 

Kaipiainen-Seppänen O, Niinisalo H, Korpilähde T, Virolainen J. Treatment of reactive arthritis with infliximab. Scandinavian J Rheumatol. 2003;32(2):122–4. https://doi.org/10.1080/03009740310000157.

Article